Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
New stent technique may keep bile ducts open longer in cancer patients
Symptom relief Not yet recruitingThis study tests a new method of placing plastic stents in the bile duct to relieve jaundice caused by cancer near the liver. About 70 patients will be randomly assigned to either the standard method or a new technique that avoids cutting the bile duct muscle. The goal is to see …
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated May 17, 2026 06:51 UTC
-
Breast cancer drug tamoxifen tested for cystic fibrosis safety
Symptom relief Not yet recruitingThis study tests if tamoxifen is safe for adults with cystic fibrosis who cannot take current CF drugs. About 35 people will take tamoxifen daily for 6 months and visit the clinic every 28 days. The main goal is to track any side effects or medical problems that occur.
Phase: PHASE2 • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC